Suppr超能文献

定义胰腺远端切除术的基准结果:一项法国多中心研究的结果。

Defining Benchmark Outcomes for Distal Pancreatectomy: Results of a French Multicentric Study.

机构信息

Department of Digestive Surgery and Transplantation, Lille University Hospital, Lille, France.

Department of Digestive, Hepatobiliary and Pancreatic Surgery, Cochin Teaching Hospital, AP-HP, Université de Paris, Paris, France.

出版信息

Ann Surg. 2023 Jul 1;278(1):103-109. doi: 10.1097/SLA.0000000000005539. Epub 2022 Jun 28.

Abstract

OBJECTIVE

Defining robust and standardized outcome references for distal pancreatectomy (DP) by using Benchmark analysis.

BACKGROUND

Outcomes after DP are recorded in medium or small-sized studies without standardized analysis. Therefore, the best results remain uncertain.

METHODS

This multicenter study included all patients undergoing DP for resectable benign or malignant tumors in 21 French expert centers in pancreas surgery from 2014 to 2018. A low-risk cohort defined by no significant comorbidities was analyzed to establish 18 outcome benchmarks for DP. These values were tested in high risk, minimally invasive and benign tumor cohorts.

RESULTS

A total of 1188 patients were identified and 749 low-risk patients were screened to establish Benchmark cut-offs. Therefore, Benchmark rate for mini-invasive approach was ≥36.8%. Benchmark cut-offs for postoperative mortality, major morbidity grade ≥3a and clinically significant pancreatic fistula rates were 0%, ≤27%, and ≤28%, respectively. The benchmark rate for readmission was ≤16%. For patients with pancreatic adenocarcinoma, cut-offs were ≥75%, ≥69.5%, and ≥66% for free resection margins (R0), 1-year disease-free survival and 3-year overall survival, respectively. The rate of mini-invasive approach in high-risk cohort was lower than the Benchmark cut-off (34.1% vs ≥36.8%). All Benchmark cut-offs were respected for benign tumor group. The proportion of benchmark cases was correlated to outcomes of DP. Centers with a majority of low-risk patients had worse results than those operating complex cases.

CONCLUSION

This large-scale study is the first benchmark analysis of DP outcomes and provides robust and standardized data. This may allow for comparisons between surgeons, centers, studies, and surgical techniques.

摘要

目的

通过基准分析为胰体尾切除术(DP)定义稳健且标准化的结果参考。

背景

DP 后的结果在没有标准化分析的中小规模研究中记录。因此,最佳结果仍不确定。

方法

这项多中心研究纳入了 2014 年至 2018 年期间在 21 个法国胰腺外科专家中心接受可切除良性或恶性肿瘤 DP 的所有患者。对无显著合并症的低危队列进行分析,以确定 DP 的 18 项结果基准。这些值在高危、微创和良性肿瘤队列中进行了测试。

结果

共确定了 1188 例患者,筛选了 749 例低危患者以建立基准截止值。因此,微创方法的基准率≥36.8%。术后死亡率、主要并发症≥3a 级和有临床意义的胰瘘率的基准截止值分别为 0%、≤27%和≤28%。再入院率的基准值≤16%。对于胰腺腺癌患者,切缘阴性(R0)、1 年无病生存率和 3 年总生存率的基准截止值分别为≥75%、≥69.5%和≥66%。高危组的微创方法比例低于基准截止值(34.1% vs ≥36.8%)。良性肿瘤组所有基准截止值均得到尊重。基准病例的比例与 DP 的结果相关。大多数低危患者的中心手术结果不如操作复杂病例的中心。

结论

这项大规模研究是 DP 结果的首次基准分析,提供了稳健且标准化的数据。这可能允许外科医生、中心、研究和手术技术之间进行比较。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验